238 related articles for article (PubMed ID: 24359609)
41. KCNQ channels in nociceptive cold-sensing trigeminal ganglion neurons as therapeutic targets for treating orofacial cold hyperalgesia.
Abd-Elsayed AA; Ikeda R; Jia Z; Ling J; Zuo X; Li M; Gu JG
Mol Pain; 2015 Jul; 11():45. PubMed ID: 26227020
[TBL] [Abstract][Full Text] [Related]
42. Activation of cyclin-dependent kinase 5 broadens action potentials in human sensory neurons.
Tiwari MN; Hall BE; Ton AT; Ghetti R; Terse A; Amin N; Chung MK; Kulkarni AB
Mol Pain; 2023; 19():17448069231218353. PubMed ID: 37982142
[TBL] [Abstract][Full Text] [Related]
43. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
[TBL] [Abstract][Full Text] [Related]
44. Cyclin-dependent kinase 5 regulates E2F transcription factor through phosphorylation of Rb protein in neurons.
Futatsugi A; Utreras E; Rudrabhatla P; Jaffe H; Pant HC; Kulkarni AB
Cell Cycle; 2012 Apr; 11(8):1603-10. PubMed ID: 22456337
[TBL] [Abstract][Full Text] [Related]
45. Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells.
Lee JH; Kim KT
J Neurochem; 2004 Nov; 91(3):634-47. PubMed ID: 15485494
[TBL] [Abstract][Full Text] [Related]
46. Cdk5-Dependent Phosphorylation of Ca
Gomez K; Calderón-Rivera A; Sandoval A; González-Ramírez R; Vargas-Parada A; Ojeda-Alonso J; Granados-Soto V; Delgado-Lezama R; Felix R
J Neurosci; 2020 Jan; 40(2):283-296. PubMed ID: 31744861
[TBL] [Abstract][Full Text] [Related]
47. p35 and Rac1 underlie the neuroprotection and cognitive improvement induced by CDK5 silencing.
Posada-Duque RA; López-Tobón A; Piedrahita D; González-Billault C; Cardona-Gomez GP
J Neurochem; 2015 Jul; 134(2):354-70. PubMed ID: 25864429
[TBL] [Abstract][Full Text] [Related]
48. Pctaire1 interacts with p35 and is a novel substrate for Cdk5/p35.
Cheng K; Li Z; Fu WY; Wang JH; Fu AK; Ip NY
J Biol Chem; 2002 Aug; 277(35):31988-93. PubMed ID: 12084709
[TBL] [Abstract][Full Text] [Related]
49. Intraganglionar resiniferatoxin prevents orofacial inflammatory and neuropathic hyperalgesia.
Cruz LS; Kopruszinski CM; Chichorro JG
Behav Pharmacol; 2014 Apr; 25(2):112-8. PubMed ID: 24557321
[TBL] [Abstract][Full Text] [Related]
50. Implication of the chemokine CCL2 in trigeminal nociception and traumatic neuropathic orofacial pain.
Dauvergne C; Molet J; Reaux-Le Goazigo A; Mauborgne A; Mélik-Parsadaniantz S; Boucher Y; Pohl M
Eur J Pain; 2014 Mar; 18(3):360-75. PubMed ID: 23918315
[TBL] [Abstract][Full Text] [Related]
51. Two Degradation Pathways of the p35 Cdk5 (Cyclin-dependent Kinase) Activation Subunit, Dependent and Independent of Ubiquitination.
Takasugi T; Minegishi S; Asada A; Saito T; Kawahara H; Hisanaga S
J Biol Chem; 2016 Feb; 291(9):4649-57. PubMed ID: 26631721
[TBL] [Abstract][Full Text] [Related]
52. Resveratrol inhibits Cdk5 activity through regulation of p35 expression.
Utreras E; Terse A; Keller J; Iadarola MJ; Kulkarni AB
Mol Pain; 2011 Jul; 7():49. PubMed ID: 21736731
[TBL] [Abstract][Full Text] [Related]
53. A nestin scaffold links Cdk5/p35 signaling to oxidant-induced cell death.
Sahlgren CM; Pallari HM; He T; Chou YH; Goldman RD; Eriksson JE
EMBO J; 2006 Oct; 25(20):4808-19. PubMed ID: 17036052
[TBL] [Abstract][Full Text] [Related]
54. Connexin 43 contributes to ectopic orofacial pain following inferior alveolar nerve injury.
Kaji K; Shinoda M; Honda K; Unno S; Shimizu N; Iwata K
Mol Pain; 2016; 12():. PubMed ID: 27030716
[TBL] [Abstract][Full Text] [Related]
55. Cyclin-dependent kinase 5/p35 contributes synergistically with Reelin/Dab1 to the positioning of facial branchiomotor and inferior olive neurons in the developing mouse hindbrain.
Ohshima T; Ogawa M; Takeuchi K; Takahashi S; Kulkarni AB; Mikoshiba K
J Neurosci; 2002 May; 22(10):4036-44. PubMed ID: 12019323
[TBL] [Abstract][Full Text] [Related]
56. The role of cyclin-dependent kinase 5 in neuropathic pain.
Gomez K; Vallecillo TGM; Moutal A; Perez-Miller S; Delgado-Lezama R; Felix R; Khanna R
Pain; 2020 Dec; 161(12):2674-2689. PubMed ID: 32773603
[TBL] [Abstract][Full Text] [Related]
57. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
[TBL] [Abstract][Full Text] [Related]
58. Crosstalk between Cdk5/p35 and ERK1/2 signalling mediates spinal astrocyte activity via the PPARγ pathway in a rat model of chronic constriction injury.
Zhong Y; Chen J; Chen J; Chen Y; Li L; Xie Y
J Neurochem; 2019 Oct; 151(2):166-184. PubMed ID: 31314915
[TBL] [Abstract][Full Text] [Related]
59. The Cdk5 kinase downregulates ATP-gated ionotropic P2X3 receptor function via serine phosphorylation.
Nair A; Simonetti M; Fabbretti E; Nistri A
Cell Mol Neurobiol; 2010 May; 30(4):505-9. PubMed ID: 19960242
[TBL] [Abstract][Full Text] [Related]
60. Calpastatin, an endogenous calpain-inhibitor protein, regulates the cleavage of the Cdk5 activator p35 to p25.
Sato K; Minegishi S; Takano J; Plattner F; Saito T; Asada A; Kawahara H; Iwata N; Saido TC; Hisanaga S
J Neurochem; 2011 May; 117(3):504-15. PubMed ID: 21338355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
